These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21280983)

  • 1. Autologous transplantation of lentivector/acid ceramidase-transduced hematopoietic cells in nonhuman primates.
    Walia JS; Neschadim A; Lopez-Perez O; Alayoubi A; Fan X; Carpentier S; Madden M; Lee CJ; Cheung F; Jaffray DA; Levade T; McCart JA; Medin JA
    Hum Gene Ther; 2011 Jun; 22(6):679-87. PubMed ID: 21280983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo delivery of human acid ceramidase via cord blood transplantation and direct injection of lentivirus as novel treatment approaches for Farber disease.
    Ramsubir S; Nonaka T; Girbés CB; Carpentier S; Levade T; Medin JA
    Mol Genet Metab; 2008 Nov; 95(3):133-41. PubMed ID: 18805722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell disease.
    Urbinati F; Wherley J; Geiger S; Fernandez BC; Kaufman ML; Cooper A; Romero Z; Marchioni F; Reeves L; Read E; Nowicki B; Grassman E; Viswanathan S; Wang X; Hollis RP; Kohn DB
    Cytotherapy; 2017 Sep; 19(9):1096-1112. PubMed ID: 28733131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic hematopoietic cell transplantation in Farber disease.
    Ehlert K; Levade T; Di Rocco M; Lanino E; Albert MH; Führer M; Jarisch A; Güngör T; Ayuk F; Vormoor J
    J Inherit Metab Dis; 2019 Mar; 42(2):286-294. PubMed ID: 30815900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor.
    Dunbar CE; Seidel NE; Doren S; Sellers S; Cline AP; Metzger ME; Agricola BA; Donahue RE; Bodine DM
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11871-6. PubMed ID: 8876230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human CD34+ hematopoietic progenitor cell-directed lentiviral-mediated gene therapy in a xenotransplantation model of lysosomal storage disease.
    Hofling AA; Devine S; Vogler C; Sands MS
    Mol Ther; 2004 Jun; 9(6):856-65. PubMed ID: 15194052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained high-level polyclonal hematopoietic marking and transgene expression 4 years after autologous transplantation of rhesus macaques with SIV lentiviral vector-transduced CD34+ cells.
    Kim YJ; Kim YS; Larochelle A; Renaud G; Wolfsberg TG; Adler R; Donahue RE; Hematti P; Hong BK; Roayaei J; Akagi K; Riberdy JM; Nienhuis AW; Dunbar CE; Persons DA
    Blood; 2009 May; 113(22):5434-43. PubMed ID: 19339698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient in vivo beta-globin production after lentiviral gene transfer to hematopoietic stem cells in the nonhuman primate.
    Hayakawa J; Ueda T; Lisowski L; Hsieh MM; Washington K; Phang O; Metzger M; Krouse A; Donahue RE; Sadelain M; Tisdale JF
    Hum Gene Ther; 2009 Jun; 20(6):563-72. PubMed ID: 19222366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic ceramide accumulation leads to severe and varied pathological consequences.
    Alayoubi AM; Wang JC; Au BC; Carpentier S; Garcia V; Dworski S; El-Ghamrasni S; Kirouac KN; Exertier MJ; Xiong ZJ; Privé GG; Simonaro CM; Casas J; Fabrias G; Schuchman EH; Turner PV; Hakem R; Levade T; Medin JA
    EMBO Mol Med; 2013 Jun; 5(6):827-42. PubMed ID: 23681708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral vector-mediated transduction of murine CD34(-) hematopoietic stem cells.
    Tahara-Hanaoka S; Sudo K; Ema H; Miyoshi H; Nakauchi H
    Exp Hematol; 2002 Jan; 30(1):11-7. PubMed ID: 11823032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34
    Río P; Navarro S; Guenechea G; Sánchez-Domínguez R; Lamana ML; Yañez R; Casado JA; Mehta PA; Pujol MR; Surrallés J; Charrier S; Galy A; Segovia JC; Díaz de Heredia C; Sevilla J; Bueren JA
    Blood; 2017 Sep; 130(13):1535-1542. PubMed ID: 28801449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASAH1 pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy.
    Elsea SH; Solyom A; Martin K; Harmatz P; Mitchell J; Lampe C; Grant C; Selim L; Mungan NO; Guelbert N; Magnusson B; Sundberg E; Puri R; Kapoor S; Arslan N; DiRocco M; Zaki M; Ozen S; Mahmoud IG; Ehlert K; Hahn A; Gokcay G; Torcoletti M; Ferreira CR
    Hum Mutat; 2020 Sep; 41(9):1469-1487. PubMed ID: 32449975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid Ceramidase Deficiency is characterized by a unique plasma cytokine and ceramide profile that is altered by therapy.
    Dworski S; Lu P; Khan A; Maranda B; Mitchell JJ; Parini R; Di Rocco M; Hugle B; Yoshimitsu M; Magnusson B; Makay B; Arslan N; Guelbert N; Ehlert K; Jarisch A; Gardner-Medwin J; Dagher R; Terreri MT; Lorenco CM; Barillas-Arias L; Tanpaiboon P; Solyom A; Norris JS; He X; Schuchman EH; Levade T; Medin JA
    Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):386-394. PubMed ID: 27915031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rAAV-mediated over-expression of acid ceramidase prevents retinopathy in a mouse model of Farber lipogranulomatosis.
    Zhang H; Nagree MS; Liu H; Pan X; Medin JA; Lipinski DM
    Gene Ther; 2023 Apr; 30(3-4):297-308. PubMed ID: 35902747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.
    Verhoeyen E; Roman-Rodriguez FJ; Cosset FL; Levy C; Rio P
    Curr Gene Ther; 2017; 16(5):297-308. PubMed ID: 28067165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid Sphingomyelinase Deficiency Ameliorates Farber Disease.
    Beckmann N; Becker KA; Kadow S; Schumacher F; Kramer M; Kühn C; Schulz-Schaeffer WJ; Edwards MJ; Kleuser B; Gulbins E; Carpinteiro A
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroviral gene transduction of adult peripheral blood or marrow-derived CD34+ cells for six hours without growth factors or on autologous stroma does not improve marking efficiency assessed in vivo.
    Emmons RV; Doren S; Zujewski J; Cottler-Fox M; Carter CS; Hines K; O'Shaughnessy JA; Leitman SF; Greenblatt JJ; Cowan K; Dunbar CE
    Blood; 1997 Jun; 89(11):4040-6. PubMed ID: 9166843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of transgene-specific immunological tolerance in myeloablated nonhuman primates using lentivirally transduced CD34+ progenitor cells.
    Kung SK; An DS; Bonifacino A; Metzger ME; Ringpis GE; Mao SH; Chen IS; Donahue RE
    Mol Ther; 2003 Dec; 8(6):981-91. PubMed ID: 14664801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of acid ceramidase deficiency in a neonatal form of Farber disease: identification of the first large deletion in ASAH1 gene.
    Alves MQ; Le Trionnaire E; Ribeiro I; Carpentier S; Harzer K; Levade T; Ribeiro MG
    Mol Genet Metab; 2013 Jul; 109(3):276-81. PubMed ID: 23707712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation.
    Dunbar CE; Kohn DB; Schiffmann R; Barton NW; Nolta JA; Esplin JA; Pensiero M; Long Z; Lockey C; Emmons RV; Csik S; Leitman S; Krebs CB; Carter C; Brady RO; Karlsson S
    Hum Gene Ther; 1998 Nov; 9(17):2629-40. PubMed ID: 9853529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.